newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Announces Submission of Endari® Marketing Authorization Application in Kuwait

TORRANCE, Calif., July 15, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today the submission of its application for Marketing Autho